VNDA insider transactions
Vanda Pharmaceuticals Inc. (VNDA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for VNDA
- Director Mitchell Stephen Ray gifted 25,836 shares, decreasing direct ownership by 27% to 71,246 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Director Duncan Charles Cliff was granted 57,101 shares (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SEC Form 3 filed by new insider Duncan Charles Cliff3 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SEC Form 3 filed by new insider Polymeropoulos Christos Vasilios Mihael3 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SEC Form 3 filed by new insider Howell Scott Laverne3 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP & General Counsel Williams Timothy sold $350,755 worth of shares (42,434 units at $8.27), decreasing direct ownership by 10% to 377,450 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, CFO & Treasurer Moran Kevin Patrick sold $350,821 worth of shares (42,442 units at $8.27), decreasing direct ownership by 9% to 411,380 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, Chief Marketing Officer Wijkstrom Joakim sold $254,590 worth of shares (30,800 units at $8.27), decreasing direct ownership by 8% to 333,469 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos sold $1,276,971 worth of shares (156,235 units at $8.17), decreasing direct ownership by 5% to 2,704,496 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, Business Development Birznieks Gunther sold $350,730 worth of shares (42,431 units at $8.27), decreasing direct ownership by 8% to 494,197 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Director Honore Tage sold $240,900 worth of shares (30,000 units at $8.03), decreasing direct ownership by 24% to 93,469 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, Chief Marketing Officer Wijkstrom Joakim was granted 125,000 shares, increasing direct ownership by 52% to 364,269 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, Business Development Birznieks Gunther was granted 125,000 shares, increasing direct ownership by 30% to 536,628 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP & General Counsel Williams Timothy was granted 125,000 shares, increasing direct ownership by 42% to 419,884 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, CFO & Treasurer Moran Kevin Patrick was granted 125,000 shares, increasing direct ownership by 38% to 453,822 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos was granted 525,000 shares, increasing direct ownership by 22% to 2,860,731 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos bought $41,500 worth of shares (10,000 units at $4.15), increasing direct ownership by 0.43% to 2,335,731 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Director Mitchell Stephen Ray sold $32,130 worth of shares (7,000 units at $4.59), decreasing direct ownership by 7% to 97,082 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Director Mitchell Stephen Ray was granted 59,225 shares, increasing direct ownership by 132% to 104,082 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Director Chrousos Phaedra was granted 59,225 shares, increasing direct ownership by 92% to 123,350 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Director Dugan Richard W was granted 59,225 shares, increasing direct ownership by 50% to 177,454 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Director Honore Tage was granted 59,225 shares, increasing direct ownership by 92% to 123,469 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Director Ward Anne Sempowski was granted 59,225 shares, increasing direct ownership by 99% to 119,067 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos bought $43,995 worth of shares (10,000 units at $4.40), increasing direct ownership by 0.43% to 2,325,731 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos bought $84,472 worth of shares (20,000 units at $4.22), increasing direct ownership by 0.87% to 2,315,731 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos bought $50,150 worth of shares (10,000 units at $5.01), increasing direct ownership by 0.44% to 2,295,731 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos bought $50,200 worth of shares (10,000 units at $5.02), increasing direct ownership by 0.44% to 2,285,731 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, Chief Marketing Officer Wijkstrom Joakim covered exercise/tax liability with 15,520 shares, decreasing direct ownership by 6% to 239,269 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, Business Development Birznieks Gunther covered exercise/tax liability with 26,941 shares, decreasing direct ownership by 6% to 411,628 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos covered exercise/tax liability with 95,999 shares and bought $47,050 worth of shares (10,000 units at $4.71), decreasing direct ownership by 4% to 2,275,731 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, CFO & Treasurer Moran Kevin Patrick covered exercise/tax liability with 26,941 shares, decreasing direct ownership by 8% to 328,822 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP & General Counsel Williams Timothy covered exercise/tax liability with 26,941 shares, decreasing direct ownership by 8% to 294,884 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos bought $47,600 worth of shares (10,000 units at $4.76), increasing direct ownership by 0.43% to 2,361,730 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos bought $47,600 worth of shares (10,000 units at $4.76), increasing direct ownership by 0.43% to 2,351,730 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos bought $47,650 worth of shares (10,000 units at $4.76), increasing direct ownership by 0.43% to 2,341,730 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos bought $44,640 worth of shares (10,000 units at $4.46), increasing direct ownership by 0.43% to 2,331,730 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, CFO & Treasurer Moran Kevin Patrick bought $8,779 worth of shares (2,000 units at $4.39), increasing direct ownership by 0.57% to 355,763 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, Chief Marketing Officer Wijkstrom Joakim was granted 125,000 shares, increasing direct ownership by 96% to 254,789 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- President and CEO Polymeropoulos Mihael Hristos was granted 450,000 shares, increasing direct ownership by 24% to 2,321,730 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, CFO & Treasurer Moran Kevin Patrick was granted 125,000 shares, increasing direct ownership by 55% to 353,763 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, Business Development Birznieks Gunther was granted 125,000 shares, increasing direct ownership by 40% to 438,569 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP & General Counsel Williams Timothy was granted 125,000 shares, increasing direct ownership by 64% to 321,825 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Director Mitchell Stephen Ray sold $25,863 worth of shares (5,000 units at $5.17), decreasing direct ownership by 10% to 44,857 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SVP, CFO & Treasurer Moran Kevin Patrick sold $13,327 worth of shares (2,251 units at $5.92), decreasing direct ownership by 0.97% to 228,763 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Chrousos Phaedra was granted 21,887 shares, increasing direct ownership by 52% to 64,125 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Honore Tage was granted 20,529 shares, increasing direct ownership by 47% to 64,244 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Dugan Richard W was granted 20,529 shares, increasing direct ownership by 21% to 118,229 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Mitchell Stephen Ray was granted 20,529 shares, increasing direct ownership by 70% to 49,857 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Ward Anne Sempowski was granted 20,529 shares, increasing direct ownership by 52% to 59,842 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Wijkstrom Joakim sold $71,921 worth of shares (16,727 units at $4.30), decreasing direct ownership by 11% to 129,789 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Williams Timothy sold $73,313 worth of shares (17,088 units at $4.29), decreasing direct ownership by 8% to 196,825 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Birznieks Gunther sold $73,379 worth of shares (17,411 units at $4.21), decreasing direct ownership by 5% to 313,569 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Moran Kevin Patrick sold $63,393 worth of shares (14,700 units at $4.31), decreasing direct ownership by 6% to 231,014 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Polymeropoulos Mihael Hristos sold $231,339 worth of shares (55,172 units at $4.19), decreasing direct ownership by 3% to 1,871,730 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Williams Timothy was granted 125,000 shares, increasing direct ownership by 141% to 213,913 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Polymeropoulos Mihael Hristos was granted 450,000 shares, increasing direct ownership by 30% to 1,926,902 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Moran Kevin Patrick was granted 125,000 shares, increasing direct ownership by 104% to 245,714 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Wijkstrom Joakim was granted 32,700 shares, increasing direct ownership by 29% to 146,516 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- Birznieks Gunther was granted 125,000 shares, increasing direct ownership by 61% to 330,980 units (SEC Form 4)4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
- SEC Form 4: Wijkstrom Joakim sold $21,748 worth of shares (3,724 units at $5.84), decreasing direct ownership by 3% to 113,816 units4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)